Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published on 25 July 2014 |
| Author/s |
author: Oscar Arrieta |
| Publication date | July 25, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |